Congratulations to Dr. Pascal Bernatchez and team on the successful renewal of their University of British Columbia Research Excellence Cluster – The UBC Advanced Angiotensin Therapeutics Network. Initially funding in 2022/2023 as a new emerging cluster, this unit has now been renewed. Research Excellence Clusters are interdisciplinary networks of researchers addressing societal and cultural problems, and working together to solve challenges that transcend traditional boundaries associated with departments, institutions, and funding agencies
AATHEN – The UBC Advanced Angiotensin Therapeutics Network
Angiotensin receptor blockers are well-established anti-hypertensive medications with a long list of therapeutic effects in non-blood pressure-related diseases. The multi-Centre, tri-Faculty UBC Advanced Angiotensin Therapeutics Network (AATHEN) was created to facilitate collaborations aimed at optimizing the pleiotropic properties of angiotensin receptor blockers and develop non-blood pressure lowering analog compounds.
Cluster Lead: Pascal Bernatchez